Healthcare provider profile · identity verified

Christopher Sweeney, MD

Family Practice · CINCINNATI, OH · NPI 1639135965

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	572	160
Amlodipine Besylate	Amlodipine Besylate	487	132
Rosuvastatin Calcium	Rosuvastatin Calcium	464	126
Lisinopril	Lisinopril	302	84
Pantoprazole Sodium	Pantoprazole Sodium	297	81
Levothyroxine Sodium	Levothyroxine Sodium	287	76
Omeprazole	Omeprazole	280	80
Metformin Hcl Er	Metformin Hcl	265	83
Trazodone Hcl	Trazodone Hcl	264	70
Losartan Potassium	Losartan Potassium	219	66
Escitalopram Oxalate	Escitalopram Oxalate	203	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	28
Sertraline Hcl	Sertraline Hcl	180	49
Metformin Hcl	Metformin Hcl	179	51
Gabapentin	Gabapentin	172	42
Metoprolol Tartrate	Metoprolol Tartrate	170	46
Alendronate Sodium	Alendronate Sodium	154	46
Eliquis	Apixaban	154	31
Tamsulosin Hcl	Tamsulosin Hcl	152	49
Hydrochlorothiazide	Hydrochlorothiazide	151	41
Furosemide	Furosemide	150	47
Albuterol Sulfate Hfa	Albuterol Sulfate	136	59
Duloxetine Hcl	Duloxetine Hcl	131	30
Tramadol Hcl	Tramadol Hcl	128	28
Tizanidine Hcl	Tizanidine Hcl	123	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	118	33
Amoxicillin	Amoxicillin	115	85
Metoprolol Succinate	Metoprolol Succinate	115	37
Potassium Chloride	Potassium Chloride	112	24
Simvastatin	Simvastatin	111	36
Montelukast Sodium	Montelukast Sodium	109	30
Lorazepam	Lorazepam	100	29
Fluoxetine Hcl	Fluoxetine Hcl	97	28
Venlafaxine Hcl Er	Venlafaxine Hcl	96	20
Allopurinol	Allopurinol	86	24
Azithromycin	Azithromycin	86	66
Ropinirole Hcl	Ropinirole Hcl	86	14
Cephalexin	Cephalexin	85	61
Januvia	Sitagliptin Phosphate	84	18
Prednisone	Prednisone	82	36
Jardiance	Empagliflozin	81	20
Synthroid	Levothyroxine Sodium	80	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	23
Glipizide	Glipizide	78	24
Alprazolam	Alprazolam	77	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	23
Buspirone Hcl	Buspirone Hcl	69	21
Diclofenac Sodium	Diclofenac Sodium	67	25
Carvedilol	Carvedilol	66	19
Rybelsus	Semaglutide	65	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	17
Donepezil Hcl	Donepezil Hcl	62	15
Trulicity	Dulaglutide	61	11
Ozempic	Semaglutide	60	15
Pravastatin Sodium	Pravastatin Sodium	59	16
Meloxicam	Meloxicam	58	20
Celecoxib	Celecoxib	56	15
Clonazepam	Clonazepam	51	11
Ketoconazole	Ketoconazole	51	29
Memantine Hcl	Memantine Hcl	50	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	16
Famotidine	Famotidine	48	15
Naproxen	Naproxen	48	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Bupropion Xl	Bupropion Hcl	43	12
Doxepin Hcl	Doxepin Hcl	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Finasteride	Finasteride	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Ezetimibe	Ezetimibe	38	14
Fluticasone Propionate	Fluticasone Propionate	38	22
Cefuroxime	Cefuroxime Axetil	36	25
Topiramate	Topiramate	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Fluconazole	Fluconazole	33	11
Hydrocortisone	Hydrocortisone	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Atenolol	Atenolol	32	11
Ondansetron Hcl	Ondansetron Hcl	32	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	19
Paxlovid	Nirmatrelvir/Ritonavir	31	30
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Mupirocin	Mupirocin	30	24
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Valsartan	Valsartan	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	19
Lamotrigine	Lamotrigine	23	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	20	19
Xarelto	Rivaroxaban	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	11
Pregabalin	Pregabalin	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Nystatin	Nystatin	16	suppressed
Diazepam	Diazepam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Linzess	Linaclotide	15	suppressed
Nurtec Odt	Rimegepant Sulfate	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Torsemide	Torsemide	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Sulindac	Sulindac	14	suppressed
Baclofen	Baclofen	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Nadolol	Nadolol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Restasis	Cyclosporine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error